Tissue distribution and serum kinetics of T101 monoclonal antibody during passive anti-cancer therapy
- 1 October 1986
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 41 (1), 43-54
- https://doi.org/10.1016/0090-1229(86)90050-4
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Preclinical studies on the use of selective antibody-ricin conjugates in autologous bone marrow transplantationBlood, 1985
- The use of monoclonal antibodies and flow cytometry to detect peripheral blood and bone marrow involvement of a diffuse, poorly differentiated lymphomaInternational Journal of Immunopharmacology, 1985
- Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemiaBlood, 1984
- Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody.Journal of Clinical Oncology, 1984
- Monoclonal antibody therapeutic trials in seven patients with T-cell lymphomaBlood, 1983
- In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins.The Journal of Experimental Medicine, 1982
- Murine monoclonal antibody therapy in two patients with chronic lymphocytic leukemiaBlood, 1982
- Tumour localization of monoclonal antibody against a rat mammary carcinoma and suppression of tumour growth with adriamycin-antibody conjugatesCancer Immunology, Immunotherapy, 1982
- In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemiaBlood, 1981
- Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemic cells.The Journal of Experimental Medicine, 1980